Developer of human gene-based therapies. The company has developed a platform to bring new disease-modifying therapies to patients with severe disorders. The company's pipeline includes gene-based therapies for lipoprotein lipase deficiency, or LPLD, Sanfilippo B, Parkinson's Disease and Hemophilia B.read more
Joseph Higgins ā Vice President, Clinical Development at uniQure
Executive Bio
Joseph Higgins serves as the Vice President, Clinical Development of uniQure. Joseph started at uniQure in March of 2018. Joseph currently resides in the Greater Boston Area.
Executive Team Culture Ratings from uniQure Employees
TOP
10%
uniQure's Executive Team scores in the Top 10% of similar sized companies on Comparably